Dr. Goulart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-667-2778Fax+1 206-288-1435
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2011
- University of WashingtonResidency, Internal Medicine, 2005 - 2007
- Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1997
Certifications & Licensure
- WA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 2 citationsContinuation of Third-Generation Tyrosine Kinase Inhibitors in Second-Line Trials for-Mutated Non-Small-Cell Lung Cancer: Regulatory Considerations.Bernardo H L Goulart, Erin Larkins, Julia A Beaver, Harpreet Singh
Journal of Clinical Oncology. 2023-08-10 - 7 citationsImpact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.Perrin E Romine, Qin Sun, Catherine Fedorenko, Li Li, Mariel Tang
JCO Oncology Practice. 2022-06-01 - 1 citationsEffect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung CancerCristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D. Eaton, Renato G. Martins
JCO Oncology Practice. 2021-08-10
Press Mentions
- What's a Cancer Registry?March 22nd, 2021
- MD Anderson Leads List of Top-Tier Cancer HospitalsJuly 29th, 2020
- Durvalumab Phase III Trial Could Change Mesothelioma CareMay 28th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: